![Celia Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Celia Lin is a former Medical Director-Clinical Development at Amgen, Inc. She also served as the Chief Medical Officer at Vera Therapeutics, Inc. from 2021 to 2023.
Dr. Lin holds a doctorate degree from Rochester Christian University and an undergraduate degree from the University of California, Los Angeles.
Eerdere bekende functies van Celia Lin
| Bedrijven | Functie | Einde |
|---|---|---|
| VERA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 08-01-2023 |
| AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Celia Lin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
